menu search

Solar gets burned: enphase energy falls 25%

Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy....

April 26, 2023, 9:23 pm

Erasca announces two poster presentations at the 2023 asco annual meeting

Posters will feature preliminary phase 1b combination data for potential best-in-class ERK1/2 inhibitor...

April 26, 2023, 9:00 pm

Why enphase energy has cratered after earnings

Growth is great, but that was already priced in....

April 26, 2023, 4:45 pm

Hookipa to present a trial in progress poster on its prostate cancer phase 1/2 clinical trial at asco

NEW YORK and VIENNA, Austria, April 26, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class ...

April 26, 2023, 3:30 pm

Rain oncology: phase 3 milademetan data expected q2 of 2023

Rain Oncology: phase 3 Milademetan Data Expected Q2 Of 2023....

April 26, 2023, 2:34 pm

Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic...

April 26, 2023, 2:08 pm

Allogene therapeutics announces presentation of phase 1 data from the allo-501/501a trials in large b cell lymphoma at the american society of clinical oncology (asco) annual meeting

SOUTH SAN FRANCISCO, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pi...

April 26, 2023, 2:06 pm

Galera to present one-year reductions in cisplatin-related chronic kidney disease data from roman trial at 2023 american society of clinical oncology (asco) annual meeting

MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on deve...

April 26, 2023, 2:00 pm

Enphase stock drops 25% to lowest in nearly a year as company's weak guidance spooks wall street

Enphase Energy Inc. stock on Wednesday dropped to its lowest in nearly a year as investors worried that...

April 26, 2023, 1:44 pm

Enphase energy stock tanks after earnings: time to buy on the dip?

Enphase grew revenue and adjusted EPS by 65% and 73% year over year, respectively, to kick off 2023. Sp...

April 26, 2023, 1:31 pm

Rooftop solar: ain't no sunshine

Enphase Energy points out rising interest rates and new net metering rules in California are casting a ...

April 26, 2023, 1:17 pm

Enphase energy's (enph) q1 earnings beat, revenues rise y/y

Enphase Energy's (ENPH) first-quarter revenues of $726 million beat the Zacks Consensus Estimate by 0.4...

April 26, 2023, 12:54 pm

Zeb nickel kicks off further exploration drilling at flagship project in south africa

Zeb Nickel (TSX-V:ZBNI, OTC:ZBNIF) Corp revealed that it had kicked off further exploration drilling at its flagship Zeb Nickel (TSX-V:ZBNI, OTC:ZBNIF...

April 26, 2023, 11:44 am

60 degrees pharmaceuticals awarded u.s. patent covering tafenoquine for treatment of covid-19 and other lung infections

Patent provides exclusive use through 2040 of tafenoquine for treatment of COVID-19 and other lung infections. Tafenoquine is the active molecule in 6...

April 26, 2023, 11:34 am

Evelo biosciences provides clinical updates

– Topline Data from fourth cohort of EDP1815 phase 2 trial in atopic dermatitis did not meet primary ...

April 26, 2023, 11:30 am

Uvax bio announces publication of results from preclinical studies of hiv vaccine candidates

Uvax Bio-owned vaccines demonstrated significant improvement in immune response compared with current vaccine strategies ...

April 26, 2023, 11:30 am

Novartis to present new data across oncology portfolio including kisqali phase iii natalee trial in early breast cancer at asco

Basel, April 26, 2023 — Novartis will present new data from its oncology portfolio at the 2023 American Society of Clinical Oncology (ASCO) Annual M...

April 26, 2023, 10:21 am

Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023

CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic...

April 26, 2023, 10:08 am

Usd/jpy: scope for further consolidation near term – uob

USD/JPY seems to have now moved into a consolidative phase and is likely to navigate within the 132.85-...

April 26, 2023, 9:29 am

Why is enphase energy (enph) stock down 19% today?

Enphase Energy (NASDAQ: ENPH ) stock is falling hard on Wednesday following the release of its earnings...

April 26, 2023, 9:28 am


Search within

Pages Search Results: